Pharmareferent Cardiometabolic Health (m/w/d) Gebiet (5108011): Rheine, Ahaus, Greven, Steinfurt, Dülmen

Germany

Apply with AI Apply

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

The ideal candidate should possess a relevant degree in pharmacy, biology, or a related scientific field, and have a strong understanding of cardiometabolic health and disease states. Experience in pharmaceutical sales or a similar role within the healthcare industry is preferred, along with demonstrated knowledge of the German healthcare system.

Responsibilities

As a Pharmareferent Cardiometabolic Health, you will be responsible for promoting and educating healthcare professionals about Lilly’s cardiometabolic health products, conducting product demonstrations, and providing scientific support. You will also be expected to build and maintain strong relationships with key opinion leaders and healthcare stakeholders within the designated territory, achieving sales targets and contributing to the overall growth of the business. Additionally, you will participate in medical congresses and contribute to market research activities.

Skills

Cardiometabolic Health

Pharmaceutical Sales

Territory Management

Customer Relationship Management

Medical Knowledge

Communication Skills

Negotiation Skills

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free